Meeting
2014 ASCO Annual Meeting
Evolution of heterogeneous mechanisms of acquired resistance to cetuximab-based therapy in colorectal cancer.
Authors
Clara Montagut
University Hospital del Mar - IMIM, Barcelona, Spain
Clara Montagut , Beatriz Bellosillo , Iria Gonzalez , Alejandro Martinez , Alba Dalmases , Mar Iglesias , Joana Vidal , Marta Salido , Mar Garcia , Marcos Busto , Guadalupe Aguilar , Ester Moragon , Blanca Espinet , Sergi Serrano , Ana Rovira , Joaquim Bellmunt , Joan Albanell
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 3526)
DOI
10.1200/jco.2014.32.15_suppl.3526
Abstract #
3526
Poster Bd #
15
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Blood-based genomic profiling of circulating cell-free tumor DNA (ctDNA) in 1397 patients (pts) with colorectal cancer (CRC).
First Author: John H. Strickler
Poster
2014 ASCO Annual Meeting
Molecular profiling of EGFR pathway according to location of colorectal cancer (CRC): Analysis of 1,001 patients in single institute.
First Author: Eiji Shinozaki
Poster
2014 Gastrointestinal Cancers Symposium
Prevalence of KRAS, BRAF, NRAS, PIK3CA, and PTEN alterations in colorectal cancer: Analysis of a large international cohort of 5,900 patients.
First Author: Gargi Dan Basu
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of class II and III BRAF mutations with EGFR blockade therapy response and representation of molecularly distinct subgroups of BRAF mutations in MMR proficient CRC.
First Author: Ibrahim Halil Sahin